Studies show zeaxanthin lowers risk for AMD

December 2, 2011

ZeaVision, LLC announced that three recent groundbreaking studies demonstrate that zeaxanthin, the predominate protective pigment in the back of the eye, reduces the risk for age-related macular degeneration (AMD) and benefits the treatment of advanced AMD. In 2011, two studies in Europe and Asia demonstrate that zeaxanthin lowers AMD risk. A study from the Erasmus Medical Center Rotterdam in the Netherlands demonstrates that nutrients— specifically dietary zeaxanthin— reduce the risk of early AMD.

The Beijing Tongren Eye Center in China recently published data indicating a direct correlation between higher blood serum levels of zeaxanthin and a 96 percent reduction of developing AMD. The third and most recent study in the United States, from the Retina Center of St. Louis, shows that an additional 20 mg/per day of zeaxanthin to patients undergoing therapy for advanced or wet AMD significantly reduces the number of invasive treatment cycles required.

While Zeaxanthin is naturally found in the macula as the primary protective carotenoid, it is difficult to replenish through the average daily diet. ZeaVision’s EyePromise® brand of all-natural nutraceuticals includes patented formulas that contain the highest daily doses of zeaxanthin available, derived from paprika peppers. For more, visit www.zeavision.com/stlretinastudy.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: